Case Reports in Ophthalmological Medicine · 2011 · 12 citations · 4 references
MedicineOphthalmologyVision ScienceOcular DiseaseOcular ImagingOphthalmic SurgeryMacular DiseaseMacular DisordersMacular ImagingRetinal ImagingRetinal SurgeryVitreoretinal SurgeryMacular Edema TreatmentMacular Hole ImagingOcular Coherence TomographyRetinal Vein Occlusion TherapySerious Adverse Events
Macular edema secondary to retinal vein occlusion is commonly being treated with off-label intravitreal bevacizumab with good outcomes. A significant reduction in macular edema and improvement in visual acuity is seen following such a treatment with no serious adverse effects. In the reported case, a full-thickness macular hole was noticed one month after intravitreal bevacizumab for macular edema secondary to hemicentral retinal vein occlusion. On a detailed review of the pre- and postoptical coherence tomography scans, it was realized that there was a preexisting stage 2-3 macular hole which was masked by the hemorrhages and edema at the fovea and the macular hole had progressed following the injection.
4
INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR CENTRAL AND HEMICENTRAL RETINAL VEIN OCCLUSIONS
Rogério A. Costa, Rodrigo Jorge, Daniela Calucci et al. · Retina · 2007 · 180 citations